Zahra Ghasemi: The Human Reality of IVIG Access
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn:
“Different diagnoses, one lifeline: The human reality of IVIG access!
Last year, I shared a deeply personal chapter of my life: my sister’s battle with Guillain-Barré Syndrome (GBS).
While that experience was a sudden, acute crisis, today marks the start of Primary Immunodeficiency Diseases International Awareness Week.
On the surface, these conditions seem worlds apart; one is a rare neurological attack, the other a lifelong immune deficiency, but they are bound together by a single, critical lifeline: IVIG.
Today, a global effort is shining a light on primary immunodeficiency, a group of over 400 rare, chronic disorders in which the body’s immune system is missing or functions improperly.
For millions of PID patients, IVIG is not just ‘medication’; it is their external immune system.
It is the bridge that allows a child to go to school or an adult to sustain a career.
Yet, because these therapies rely entirely on human plasma donation and complex fractionation, ‘access’ remains one of our greatest global health challenges.
Awareness is the first step toward policy change.
Whether we are industry professionals, policymakers, or citizens, we must advocate for a world in which ‘plasma, the liquid gold’ is accessible to every patient who relies on it to survive.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering